Yale Medicine School: Oncology Therapy at the End of Life - Have We Missed the Mark?
October 21, 2022
October 21, 2022
NEW HAVEN, Connecticut, Oct. 21 (TNSjou) -- Yale School of Medicine issued the following news on Oct. 21, 2022:
Continued treatment for patients with cancer near end of life delays conversations about goals of care and hospice enrollment, escalates costs, and may adversely affect the quality of care patients receive. Accordingly, over the last decade, major professional societies have recommended that clinicians decrease the use of systemic anti-cancer therapies at the end-of-life s . . .
Continued treatment for patients with cancer near end of life delays conversations about goals of care and hospice enrollment, escalates costs, and may adversely affect the quality of care patients receive. Accordingly, over the last decade, major professional societies have recommended that clinicians decrease the use of systemic anti-cancer therapies at the end-of-life s . . .